LGALS9 and metabolic dysfunction-associated steatotic liver disease: Our results support the findings of Loomis et al. that the risk of NAFLD increased linearly with BMI (57), and the report of Fujita et al. that a high Gal-9 level above 77.54 pg./mL was linked to a high probability of liver fibrosis (13).